Discover Design Deliver Who we are Lead Pharma is a clinical-stage pharmaceutical research & development company. We design and develop innovative small-molecule therapies to treat autoimmune diseases and cancer. Our team of R&D professionals offers a wealth of experience in numerous areas of drug discovery, from target identification through lead optimization to pre-clinical development. We have a proven track record of discovering, designing, and delivering pre-clinical and clinical stage candidate drugs. Our ambition Our ambition is to develop life-changing treatments for patients. For patients with cancer, our therapies target primary tumors, metastasis, treatment resistance, refractory tumors, and tumors for which the only treatment option is chemotherapy. For patients with autoimmune diseases, we aim to improve the lives of patients suffering from debilitating diseases, with a focus on oral therapies that have good efficacy and a clean safety profile. Our science Lead Pharma’s strengths in innovation rely on a powerful discovery engine that is based on comprehensive in-house capabilities and an integrated suite of cutting-edge technologies. Read more Our pipeline We are developing a pipeline of small-molecule drugs to treat autoimmune diseases and cancer. Read more Partnering Collaborations are a key part of our business strategy and we are actively seeking companies who are interested in forming new partnerships. Read more © Scicomvisuals | Privacy | Disclaimer

Loading... Our story Lead Pharma is a spinoff from the prestigious Hubrecht Institute and the University Medical Center Utrecht. We develop innovative small-molecule therapies for patients with autoimmune disease or cancer. Lead Pharma is headquartered at Pivot Park, the biopharmaceutical life sciences campus in Oss, the Netherlands. We have fully equipped labs for all stages of drug discovery, including medicinal chemistry, cellular pharmacology, and molecular pharmacology, as well as an in silico lab for our computational chemistry, bioinformatics and data mining activities. We work with a select network of specialized contract research organizations to whom we outsource our in vivo pharmacology and toxicology studies. Lead Pharma has a qualified team of 29 employees, including 10 with a PhD degree, who have long-term experience working in large pharmaceutical companies, biotech companies and academia. Our people The quality of our people is at the heart of our innovative success! Our team members have a wealth of experience when it comes to drug discovery, drug design, translational medicine, and development. The success of our team does not rely only on high quality standards and effective teamwork, but also on agility, creativity, inspiration and passion. Management Board Frans van den Berg, MSc, MBA Chief Executive Officer Arthur Oubrie, PhD Chief Scientific Officer Supervisory Board Bart Bergstein (chair) Daan van den Noort Erik van den Berg Jan Hendrik Egberts Jan van der Hoeven Investors BOM Brabant Ventures Oost NL Biox Biosciences Waterman Ventures © Scicomvisuals | Privacy | Disclaimer